3320.HK
CHINARES PHARMA
HK$4.77
+2.14%
2026-06-01
About CHINARES PHARMA
China Resources Pharmaceutical Group Limited, an investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally. It operates through four segments: Pharmaceutical Manufacturing, Pharmaceutical Distribution, Pharmaceutical Retail, and Others. The company offers a range of chemical drugs, Chinese medicines, and biological drugs, as well as nutritional and healthcare products for various therapeutic areas, including cardiovascular and cerebrovascular diseases, alimentary tract, endocrine diseases, respiratory diseases, orthopedics, nephrology, rheumatology and immunology, medical nutrition, pediatrics, genitourinary system, dermatological diseases, blood products, therapeutic infusions, antitumor drugs, medicine for cough and cold, anti-infection drugs, and psychoneurosis. It also provides warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical/medical device manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, the company is involved in property holding activities, as well as operates retail pharmacies under the Teck Soon Hong brands. It distributes its products under the 999, Dong-E-E-Jiao, Double Crane, Zizhu, Jiangzhong, Boya, and Kun Zhong Yao to hospitals and other medical institutions. The company was formerly known as China Resources Medications Group Limited and changed its name to China Resources Pharmaceutical Group Limited in December 2011. The company was incorporated in 2007 and is based in Wan Chai, Hong Kong. China Resources Pharmaceutical Group Limited is a subsidiary of CRH (Pharmaceutical) Limited.
Key Fundamentals
P/E Ratio
6.96
Forward P/E
6.13
EPS (TTM)
HK$0.74
ROE
9.0%
Revenue Growth (YoY)
6.7%
Profit Margin
1.5%
Debt/Equity
61.95
Dividend Yield
4.2%
Price/Book
0.55
Beta
-0.37
Market Cap
HK$32.35B
Avg Volume (10D)
14.8M
Recent Breakout Signals
No recent breakout signals detected for 3320.HK.
Recent Price Range (60 Days)
60D High
HK$6.53
60D Low
HK$4.34
Avg Volume
19.8M
Latest Close
HK$4.77
Get breakout alerts for 3320.HK
Sign up for Breakout Scanner to receive daily notifications when 3320.HK triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial.
CHINARES PHARMA (3320.HK) is listed on the Hong Kong Exchanges (HKEX). Breakout Scanner monitors 3320.HK daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. 3320.HK operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry. Data is provided for informational purposes only and does not constitute financial advice.